El En SpA
OTC:ELEAF
El En SpA
OTC:ELEAF
Price:
9.8 USD
Market Closed
Updated:
Apr 28, 2024
Section:
Relative Value
The Relative Value of one
ELEAF
stock under the Base Case scenario is
17.51
USD.
Compared to the current market price of 9.8 USD,
El En SpA
is
Undervalued by 44%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ELEAF
Relative Value
Base Case
17.51
USD
Undervaluation 44%
Valuation Multiples
Multiples Across Competitors
ELEAF Competitors Multiples
El En SpA Competitors
El En SpA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IT |
|
El En SpA
OTC:ELEAF
|
930.4m USD | 1.3 | 19.3 | 9.8 | 11.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.5B USD | 4.6 | 33.1 | 19.5 | 29 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 18.2 | 67 | 54.9 | 68.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.6B USD | 6.2 | 40.3 | 25.1 | 31.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 7.5 | 68.3 | 31.7 | 47.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106B USD | 3.3 | 25.2 | 13.5 | 19.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66.9B USD | 3.4 | 54.9 | 18.4 | 38.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 2.7 | 38.9 | 18.6 | 31.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.7 | 37 | 26.8 | 29 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 13.2 | 88.5 | 59.6 | 77.6 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
349.3B CNY | 10.2 | 30.8 | 26.7 | 26.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
